ANDOVER, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHI) today announced the availability of triplets monitoring functionality for its industry-leading line of obstetrical care fetal and maternal monitors, Avalon FM20 antepartum and Avalon FM30 intrapartum. Philips is the first company to introduce a fetal monitor that enables non-invasive triplets monitoring with a single device.
